GlassScriptPhysician profile
Rona M Mckenzie
NPI 1851450530
$3,557.65
in general payments reported to CMS, 2019-2025
33 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $566 · 2021: $430 · 2022: $468 · 2023: $837 · 2024: $332 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $703.30 | 2019-2024 | Breztri |
| Inari Medical, INC. | $422.12 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $313.10 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $247.08 | 2019-2024 | |
| Pfizer INC. | $198.84 | 2019-2025 | |
| Lilly USA, LLC | $174.12 | 2022-2025 | Mounjaro, Zepbound, Lyumjev |
| Glaxosmithkline, LLC. | $135.45 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $124.93 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $118.23 | 2019-2022 | |
| Astellas Pharma US INC | $114.28 | 2022-2024 | Veozah, Myrbetriq |
| Angiodynamics, INC. | $107.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.21 | 2022 | |
| Baxter Healthcare | $83.16 | 2019 | |
| Amgen INC. | $77.89 | 2024-2025 | Repatha, Krystexxa, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.26 | 2019-2025 | Jardiance |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $59.43 | 2020-2025 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.83 | 2020-2024 | Xifaxan |
| Exact Sciences Corporation | $57.79 | 2023-2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $52.82 | 2020-2021 | |
| Avion Pharmaceuticals | $42.84 | 2020-2021 | |
| Abbott Laboratories | $40.78 | 2022 | |
| Novartis Pharmaceuticals Corporation | $30.68 | 2019-2022 | |
| Hologic Sales and Service, LLC | $29.34 | 2025 | Affirm Prone Biopsy System |
| Vifor Pharma, INC. | $24.59 | 2023 | Veltassa |
| Genzyme Corporation | $23.83 | 2023 | |
| Philips North America LLC | $22.66 | 2019 | |
| Mayne Pharma Commercial LLC | $22.05 | 2023 | |
| Arbor Pharmaceuticals, INC. | $21.07 | 2020 | |
| Sumitomo Pharma America, INC. | $20.82 | 2023 | Gemtesa |
| Corcept Therapeutics | $18.39 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.00 | 2022 | |
| Millicent US INC | $15.81 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rona Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.